Breast Cancer Treatment: The TAILORx Clinical Trial

TAILORx clinical trial findings will help personalize breast cancer treatment decisions.Earlier this month, the long-awaited results of the TAILORx clinical trial were announced.

The findings from this study are important for early stage breast cancer patients with hormone receptor-positive breast cancer. The study results are expected to assist many patients in this group in determining whether chemotherapy should be part of their treatment.

The TAILORx findings are also interesting when viewed as part of a developing trend in treatment for early stage breast cancer away from a one-size-fits all approach toward more personalized care.

The findings were presented at the annual meeting of the American Society for Clinical Oncology (ASCO) and also published in the New England Journal of Medicine (NEJM). Continue reading

5 Cancer Research Stories Worth Following – Summer 2016

Cancer research stories worth following this summer include a study on extending the use of aromatase inhibitors in the treatment of hormone receptor-positive breast cancer.What’s exciting in cancer research right now? In this post, I’ll review several of the most interesting cancer research stories that have been in the news this summer.

These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.

Stories worth following include several studies presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in June.  Among those were a study on extending the use of aromatase inhibitors in breast cancer treatment; findings that a web app boosts survival for patients with lung cancer; and, research on the use of a “biosimilar” treatment that can substitute for the breast cancer drug Herceptin. Continue reading

Top Cancer Research Stories: Early Summer 2014

Daylily in early summer gardenThis is the latest post in a bi-monthly series where we take a look at several of the most interesting cancer research stories that have come out over the previous two months. These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.

In early May, the American Society of Clinical Oncology (ASCO) held its annual meeting in Chicago. In the area of breast cancer treatment, this meeting included reports on several interesting studies about ways that patients can benefit from new uses of existing drugs.

Continue reading

Top Cancer Research Stories: Spring 2014

Laptop, newspaper and coffeeThis is the latest post in a bi-monthly series where we take a look at several of the most interesting cancer research stories that have come out over the previous two months. These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.

Below are overviews of a number of the top cancer research stories that came out during March – April 2014. Also, in March, a study reported in the Journal of American Medical Association reviewed what is known about the benefits and harms of screening mammography from studies conducted over the past several decades–I’ve written about the take-home messages in a recent post. Continue reading